Shanghai Clinical Cohort - Adrenal Disease

As a vital organ responsible for producing life-sustaining hormones, the adrenal gland is associated with a wide range of diseases. These diseases affect multiple systems throughout the body and carry a high rate of mortality and disability. Current diagnosis and treatment face several challenges: significant variability in hormone testing results, inaccurate localization via imaging techniques, unclear molecular characteristics of adrenal tumors, and difficulty in determining prognosis through pathology. Therefore, establishing a clinical research cohort for adrenal diseases is essential. Such a cohort will enable in-depth exploration of disease mechanisms, identification of disease subtypes, optimization of diagnostic criteria, evaluation of treatment efficacy, advancement of personalized medicine, and formulation of prevention and treatment strategies.

NCT Number	NCT07191951
Lead Sponsor	Shanghai Jiao Tong University School of Medicine Collaborators: Ruijin Hospital, RenJi Hospital, Shanghai Zhongshan Hospital, Shanghai Public Health Clinical Center
Conditions	Adrenal Disease
Enrollment	600 participants
Start Date	2025-07-25
Primary Completion	2025-12-31 (estimated)
Study Completion	2025-12-31 (estimated)
Updated on ClinicalTrials.gov	2025-11-17